SR ONE CAPITAL MANAGEMENT, LLC - 11 May 2026 SCHEDULE 13D Report for Odyssey Therapeutics, Inc. Common Stock, $0.0001 par value per share (ODTX)

Filing manager: SR ONE CAPITAL MANAGEMENT, LLC
Reporting owner: SR One Capital Management, LLC
Security: Odyssey Therapeutics, Inc. Common Stock, $0.0001 par value per share
Beneficially owned shares: 3,794,883 shares
Large-stake signal: Form
SCHEDULE 13D
Active or control-oriented beneficial ownership filing.
Ownership
8%
Beneficial ownership of this reported class.
Shares
3,794,883 shares
Shares beneficially owned as disclosed.
Event date
11 May 2026
Date tied to the ownership event or amendment.
Accepted by SEC
18 May 2026
EDGAR acceptance date.
How to read this large-stake filing
Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
Compare this filing with the holder history and issuer page before treating the percentage as a current position.
Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership: 8%
Symbol: ODTX
Shares outstanding: 47,436,038 shares
SEC form: SCHEDULE 13D
Accepted by SEC: 18 May 2026, 18:29:41 UTC
Event date: 11 May 2026
Source filing: View source filing

Key filing fact

SR ONE CAPITAL MANAGEMENT, LLC disclosed 8% ownership in Odyssey Therapeutics, Inc. Common Stock, $0.0001 par value per share (ODTX) on 11 May 2026.

Key facts

SR ONE CAPITAL MANAGEMENT, LLC filed SCHEDULE 13D for Odyssey Therapeutics, Inc. Common Stock, $0.0001 par value per share (ODTX).
Disclosed ownership: 8%.
Date of event: 11 May 2026.

This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares owned	Shared voting power	Signature	Title	CIK
SR One Capital Management, LLC	8%	3,794,883	3,794,883	/s/ Sasha Keough	Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member	0001853723
SR One Capital Fund I Aggregator, LP	3.9%	1,831,383	1,831,383	/s/ Sasha Keough	Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
SR One Capital Partners I, LP	3.9%	1,831,383	1,831,383	/s/ Sasha Keough	Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
SR One Co-Invest IV, LLC	0.8%	374,335	374,335	/s/ Sasha Keough	Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
SR One Co-Invest IV-A, LLC	1.2%	574,314	574,314	/s/ Sasha Keough	Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
SR One Co-Invest IV Manager, LLC	2%	948,649	948,649	/s/ Sasha Keough	Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
AMZL, LP	2.2%	1,014,851	1,014,851	/s/ Sasha Keough	Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
SR One Capital SMA Partners, LP	2.2%	1,014,851	1,014,851	/s/ Sasha Keough	Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
Simeon George	8%	3,794,883	3,794,883	/s/ Sasha Keough	Sasha Keough, as attorney-in-fact for Simeon George, M.D.

CIK / CUSIP context first

Broader feeds